Paediatric procedural sedation and analgesia by emergency physicians in a country with a recent establishment of emergency medicine
OBJECTIVES: Paediatric patients receive less procedural sedation and analgesia (PSA) in the emergency department compared with adults, especially in countries where emergency medicine is at an early stage of development. The objectives of this study were to evaluate the adverse events and efficacy of paediatric PSA in a country with a recent establishment of emergency medicine and to describe which factors aided implementation.
METHODS: This is a prospective, multicentre, observational study of paediatric patients undergoing PSA by the first trained emergency physicians (EPs) in The Netherlands. A standardized data collection form was used at all participating hospitals to collect data on adverse events, amnesia, pain scores, and procedure completion. A survey was used to interpret which factors had aided PSA implementation.
RESULTS: We recorded 351 paediatric PSA. The mean age was 9.5 years (95% confidence interval: 9.1-10.0). Esketamine was most frequently used (42.4%), followed by propofol (34.7%). The adverse event rate was low (3.0%). Amnesia was present in 86.8%. The median pain score was 2 (out of 10) for patients without amnesia. Procedures were successfully completed in 93.9% of the cases.
CONCLUSION: Paediatric PSA provided by the first EPs in The Netherlands showed appropriate levels of sedation and analgesia with a high rate of procedure completion and a low rate of adverse events. Our paper suggests that EPs provided with a proper infrastructure of mentorship, training and guidelines can implement effective paediatric PSA.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
European journal of emergency medicine : official journal of the European Society for Emergency Medicine - 26(2019), 3 vom: 17. Juni, Seite 168-173 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kuypers, Maybritt I [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 10.12.2019 Date Revised 17.12.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/MEJ.0000000000000524 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM279051476 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM279051476 | ||
| 003 | DE-627 | ||
| 005 | 20231225022051.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/MEJ.0000000000000524 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0930.xml |
| 035 | |a (DE-627)NLM279051476 | ||
| 035 | |a (NLM)29240569 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kuypers, Maybritt I |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Paediatric procedural sedation and analgesia by emergency physicians in a country with a recent establishment of emergency medicine |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.12.2019 | ||
| 500 | |a Date Revised 17.12.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVES: Paediatric patients receive less procedural sedation and analgesia (PSA) in the emergency department compared with adults, especially in countries where emergency medicine is at an early stage of development. The objectives of this study were to evaluate the adverse events and efficacy of paediatric PSA in a country with a recent establishment of emergency medicine and to describe which factors aided implementation | ||
| 520 | |a METHODS: This is a prospective, multicentre, observational study of paediatric patients undergoing PSA by the first trained emergency physicians (EPs) in The Netherlands. A standardized data collection form was used at all participating hospitals to collect data on adverse events, amnesia, pain scores, and procedure completion. A survey was used to interpret which factors had aided PSA implementation | ||
| 520 | |a RESULTS: We recorded 351 paediatric PSA. The mean age was 9.5 years (95% confidence interval: 9.1-10.0). Esketamine was most frequently used (42.4%), followed by propofol (34.7%). The adverse event rate was low (3.0%). Amnesia was present in 86.8%. The median pain score was 2 (out of 10) for patients without amnesia. Procedures were successfully completed in 93.9% of the cases | ||
| 520 | |a CONCLUSION: Paediatric PSA provided by the first EPs in The Netherlands showed appropriate levels of sedation and analgesia with a high rate of procedure completion and a low rate of adverse events. Our paper suggests that EPs provided with a proper infrastructure of mentorship, training and guidelines can implement effective paediatric PSA | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Observational Study | |
| 650 | 7 | |a Propofol |2 NLM | |
| 650 | 7 | |a YI7VU623SF |2 NLM | |
| 700 | 1 | |a Smits, Gaël J P |e verfasserin |4 aut | |
| 700 | 1 | |a Baerends, Eva P |e verfasserin |4 aut | |
| 700 | 1 | |a Oskam, Erick |e verfasserin |4 aut | |
| 700 | 1 | |a Reijners, Eef P J |e verfasserin |4 aut | |
| 700 | 1 | |a Mignot-Evers, Lisette A A |e verfasserin |4 aut | |
| 700 | 1 | |a Thijssen, Wendy A M H |e verfasserin |4 aut | |
| 700 | 1 | |a Plötz, Frans B |e verfasserin |4 aut | |
| 700 | 1 | |a Korsten, Erik H M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of emergency medicine : official journal of the European Society for Emergency Medicine |d 1997 |g 26(2019), 3 vom: 17. Juni, Seite 168-173 |w (DE-627)NLM088540693 |x 1473-5695 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2019 |g number:3 |g day:17 |g month:06 |g pages:168-173 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/MEJ.0000000000000524 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2019 |e 3 |b 17 |c 06 |h 168-173 | ||